Lyfe Group Corp.
$4,733,065.00 CAD
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- April 19, 2021 – May 1, 2023
- Reference
- feddevontario:062-2026-2027-Q1-00030
Published purpose
To purchase hydroxypropyl methylcellulose (HPMC) capsule manufacturing equipment and modify the facility to accommodate an increase in capsule production.
In plain English AI-generated
This grant supports Lyfe Group Corp. in purchasing equipment and modifying its facility to increase production of hydroxypropyl methylcellulose (HPMC) capsules, a type of pharmaceutical capsule.
Category: Other Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.